4. Reduce Dangerous Visceral Fat
As mentioned, GLP-1 drugs support metabolic health by contributing to weight loss, which leads to improvements in metabolic health markers such as blood pressure, insulin sensitivity, triglycerides, and cholesterol. One study involving 3,389 people with obesity suggested taking GLP-1s for one year could result in losing 10 percent or more of their body weight.
Notably the medication can lead to visceral fat loss, which is the potentially dangerous fat in the abdominal area that surrounds the organs. Visceral fat may contribute to health issues like heart disease, dementia, asthma, and cancer.
GLP-1 drugs also may limit liver fat accumulation and are being explored as a treatment option for nonalcoholic fatty liver disease, which is common among people with diabetes.
Read the full article here
